Daxor Corp (DXR) Files Form 4 Insider Buying : Michael Richard Feldschuh Buys 200 Shares

Daxor Corp (DXR): Michael Richard Feldschuh , CEO of Daxor Corp purchased 200 shares on Apr 14, 2016. The Insider buying transaction was reported by the company on Apr 18, 2016 to the Securities and Exchange Commission. The shares were purchased at $8.07 per share for a total value of $1,613.92 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 12, 2016, Michael Richard Feldschuh (CEO) purchased 200 shares at $8.06 per share price.On Apr 13, 2015, Diane Marie Meegan (Corporate Secretary) sold 1,000 shares at $7.69 per share price.Also, On Apr 6, 2015, Joseph Feldschuh (CEO) purchased 300 shares at $5.66 per share price.

Shares of Daxor Corporation (DXR) ended Friday, Apr 15, 2016 session in red amid volatile trading. The shares closed down -0.0096 points or -0.12% at $8.06 with 1,090 shares getting traded. Post opening the session at $8.05, the shares hit an intraday low of $8.05 and an intraday high of $8.06 and the price vacillated in this range throughout the day. The company has a market cap of $31 M and the number of outstanding shares has been calculated to be 38,52,488 shares. The 52-week high of Daxor Corporation is $9.1799 and the 52-week low is $5.99.

Daxor Corporation Money Flow Index Chart

Currently the company Insiders own 81.15% of Daxor Corporation shares according to the proxy statements.Institutional Investors own 3.87% of Daxor Corporation shares.

Daxor Corporation is a medical instrumentation and biotechnology company. The Company designed and developed the BVA-100 Blood Volume Analyzer. BVA-100 Blood Volume Analyzer provides direct measurement of a patient’s blood volume. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. The BVA-100 is used to diagnose and treat patients with heart failure kidney failure hypertension and syncope and to aid in fluid and blood transfusion management. The BVA-100 has also been used to aid in the diagnosis and treatment of disorders of red blood cell volume including polycythemia and anemia and to aid in pre-surgical evaluation of red blood cell volume. The Company’s IDANT division (IDANT Laboratories subsidiary) provides semen banking services which include anonymous donor semen and semen storage autologous blood storage andrology services which include semen analysis and sperm washing and general lab testing.

Leave a Reply

Daxor Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Daxor Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.